Access the comprehensive database of cell therapy developer domains. From autologous cell manufacturing to allogeneic off-the-shelf platforms, discover verified websites of cellular medicine companies revolutionizing treatment paradigms.
Navigate the cellular medicine landscape with comprehensive data on cell therapy developers and manufacturers.
Cell therapy represents a paradigm shift in medicine, using living cells as therapeutic agents to treat cancer, autoimmune diseases, and degenerative conditions. Our database provides access to autologous cell manufacturers, allogeneic platform developers, and iPSC-derived therapy companies.
Whether you're analyzing manufacturing scalability, tracking clinical outcomes, or identifying partnership opportunities, our database delivers intelligence on companies advancing cellular therapeutics from research through commercialization.
"The cell therapy market is expected to reach $25 billion by 2028, with allogeneic platforms driving the next wave of commercial growth." Our CAR-T Therapy list offers complementary insights.
-- Cell Therapy Market Report, 2024Comprehensive coverage of the cellular medicine sector. Expand your research by viewing the Stem Cell Research section.
Patient-derived cell therapies
Off-the-shelf platforms. Professionals often consult our Gene Therapy Companies data.
Induced pluripotent cells
Natural killer cells. Discover more in the Immunotherapy category.
Mesenchymal stem cells
GMP production facilities
Get instant access to 2,100+ cell therapy developer domains with comprehensive enrichment data. You may also be interested in our Regenerative Medicine dataset.
View Pricing Plans Back to Biotech & Biomedical